Alethia Biotherapeutics Inc., a developer of monoclonal antibodies for the treatment and prevention of severe bone loss, ovarian cancer and metastatic breast cancer, closed a C$9.6M Series A round of financing. The Montreal-based company will use the funds to advance its lead pre-clinical programs into clinical development. AgeChem Venture Fund, BDC Venture Capital and GO Capital Fund participated in the round.
4 min read · 07 September 2010
MeetYourFriends.com goes live. The social network site was developed by Neil Bryant, one of Badoo.com’s founders.
3 min read · 07 September 2010
3 min read · 03 September 2010
3 min read · 03 September 2010
1 min read · 03 September 2010
BankSimple raised $2.9 million from its first investment round, VentureBeat reported. First Round Capital, IA Ventures and Village Ventures participated in the financing. BankSimple has not been launched, but CEO Joshua Reich said the company has interest from 20,000 potential users, VentureBeat reported.
1 min read · 03 September 2010
Forbion Capital Partners, a Netherlands-based venture capital firm that invests in the life science sector, held the final closings of FCF I Co-Invest Fund and of FCF II. It raised a total of more than €190 million ($240 million). Forbion Capital invests in private companies developing novel drugs, medical devices and diagnostics for high- or even unmet medical needs.
3 min read · 03 September 2010
Actis invested $58 million in Companhia Sulamericana de Distribuição, which operates supermarket chains São Francisco and Cidade Canção. This marks Actis' first investment in Brazil.
3 min read · 03 September 2010
2 min read · 02 September 2010
Stentys named Stanislas Piot chief financial officer. Piot held a similar post at Ipsogen, which develops molecular diagnostic tools. Paris-based Stentys develops stents to treat heart attack patients. It is backed by Credit Agricole Private Equity, Scottish Equity Partners and Sofinnova Partners.
2 min read · 02 September 2010
